 Arcutis Biotherapeutics Inc NASDAQ: ARQT has announced the presentation of new safety and efficacy data of roflumilast foam to treat scalp and body psoriasis. Data were presented in a late-breaking oral presentation at the American Academy of Dermatology Virtual Meeting Experience. 